The rise of Sildenafil initially fueled a period of growth for pharma, however recent changes present a murky picture for those considering a stake. Off-patent versions are eating into revenue, and ongoing litigation https://sashajjxg351472.laowaiblog.com/39839014/sildenafil-and-big-pharma-a-volatile-investment